Carmen M. Anadon
-
- Immune Cell Function and Interaction 6
- Immunotherapy and Immune Responses 5
- Immune cells in cancer 3
-
- Cancer Immunotherapy and Biomarkers 4
- CAR-T cell therapy research 3
-
- Glycosylation and Glycoproteins Research 1
- Extracellular vesicles in disease 1
- Single-cell and spatial transcriptomics 1
- Co-authors
- José R. Conejo-GarcíaSubir BiswasKyle K. PayneXiaoqing YuGunjan MandalSougata Roy ChowdhuryPatricia SwansonArnab Gupta
- Cited by
- Cancer ResearchImmunologyOncology
- Journals
- Journal of Leukocyte Biology (2 papers)Nature Communications (2 papers)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- United StatesIndiaSpain
In The Last Decade
Carmen M. Anadon
18 papers receiving 629 citations
Peers
Comparison fields: 5 of 73
- Cancer Research 141
- Immunology 187
- Oncology 195
- Molecular Biology 334
- Physiology 16
Countries citing papers authored by Carmen M. Anadon
This map shows the geographic impact of Carmen M. Anadon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmen M. Anadon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmen M. Anadon more than expected).
Fields of papers citing papers by Carmen M. Anadon
This network shows the impact of papers produced by Carmen M. Anadon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmen M. Anadon. The network helps show where Carmen M. Anadon may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Carmen M. Anadon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 17 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 5 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 3 | |
| 7 | 2022 | 23 | |
| 8 | 2022 | 9 | |
| 9 | 2022 | 4 | |
| 10 | 2020 | 9 | |
| 11 | 2020 | 1 | |
| 12 | 2019 | 111 | |
| 13 | 2019 | 39 | |
| 14 | 2019 | 5 | |
| 15 | 2019 | 164 | |
| 16 | 2018 | 70 | |
| 17 | 2015 | 95 | |
| 18 | 2012 | 74 |
About Carmen M. Anadon
Carmen M. Anadon is a scholar working on Immunology, Oncology and Immunology and Allergy, having authored 18 papers that have together received 634 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (6 papers), Immunotherapy and Immune Responses (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), CAR-T cell therapy research (3 papers), Immune cells in cancer (3 papers), Glycosylation and Glycoproteins Research (1 paper), Extracellular vesicles in disease (1 paper) and Single-cell and spatial transcriptomics (1 paper). The work is most often cited by research in Cancer Research (141 citations), Immunology (187 citations) and Oncology (195 citations). Carmen M. Anadon has collaborated with scholars based in United States, India and Spain. Frequent co-authors include José R. Conejo-García, Subir Biswas, Kyle K. Payne, Xiaoqing Yu, Gunjan Mandal, Sougata Roy Chowdhury, Patricia Swanson, Arnab Gupta, Arindam Bhattacharyya and Tara Lee Costich. Their work appears in journals such as Journal of Leukocyte Biology, Nature Communications, Molecular Cancer Therapeutics, Molecular Pharmaceutics and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.